Scancell Holdings plc (LON:SCLP – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 11.76 ($0.15) and traded as low as GBX 9.70 ($0.12). Scancell shares last traded at GBX 10.10 ($0.13), with a volume of 289,261 shares.
Scancell Price Performance
The stock has a 50 day moving average price of GBX 10.72 and a two-hundred day moving average price of GBX 11.76. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 8.63. The company has a market capitalization of £93.71 million, a PE ratio of -1,010.00 and a beta of 0.34.
About Scancell
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
Further Reading
- Five stocks we like better than Scancell
- The Significance of Brokerage Rankings in Stock Selection
- Here are the Pros and Cons of Using Options Call Debit Spreads
- Learn Technical Analysis Skills to Master the Stock Market
- Carmax Returns to the Bargain Basement: Buy the Dip?
- What is a Stock Market Index and How Do You Use Them?
- Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
